Taxanes in breast cancer: an update
- PMID: 17164044
- DOI: 10.1007/BF02951422
Taxanes in breast cancer: an update
Abstract
Over the past decade the taxanes have proved to be fundamental in the treatment of breast cancer. Initially found to have efficacy in metastatic breast cancer, the taxanes are now vital components in the treatment of early-stage disease, in which their addition to adjuvant treatment of early breast cancer has been shown to improve overall survival. In addition, the taxanes have demonstrated a role in first-line therapy for metastatic disease, with some of the highest efficacy of any class of chemotherapy. Targeted therapies in combination with the taxanes have further improved survival for both early and metastatic disease. New formulations of taxanes may both improve antitumor activity and reduce toxicity.
Similar articles
-
Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.Surg Clin North Am. 2003 Aug;83(4):943-71. doi: 10.1016/S0039-6109(03)00071-9. Surg Clin North Am. 2003. PMID: 12875604 Review.
-
Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.Clin Breast Cancer. 2000 Apr;1(1):32-40; discussion 41-2. doi: 10.3816/CBC.2000.n.002. Clin Breast Cancer. 2000. PMID: 11899388 Review.
-
Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?Expert Opin Pharmacother. 2000 Jan;1(2):187-206. doi: 10.1517/14656566.1.2.187. Expert Opin Pharmacother. 2000. PMID: 11249542 Review.
-
Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.Cancer Invest. 2009 Jun;27(5):489-95. doi: 10.1080/07357900802427943. Cancer Invest. 2009. PMID: 19479486 Review.
-
Taxanes in the adjuvant treatment of breast cancer.J Natl Compr Canc Netw. 2003 Apr;1(2):222-31. doi: 10.6004/jnccn.2003.0021. J Natl Compr Canc Netw. 2003. PMID: 19768881 Review.
Cited by
-
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy.Breast Care (Basel). 2011;6(4):279-283. doi: 10.1159/000330946. Epub 2011 Aug 19. Breast Care (Basel). 2011. PMID: 22164126 Free PMC article.
-
17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells.Oncol Rep. 2020 Jun;43(6):1928-1944. doi: 10.3892/or.2020.7563. Epub 2020 Mar 26. Oncol Rep. 2020. PMID: 32236631 Free PMC article.
-
A prospective study of docetaxel-associated pain syndrome.Support Care Cancer. 2018 Jan;26(1):203-211. doi: 10.1007/s00520-017-3836-z. Epub 2017 Jul 22. Support Care Cancer. 2018. PMID: 28733699
-
Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience.Med Oncol. 2009 Dec;26(4):386-92. doi: 10.1007/s12032-008-9133-4. Epub 2008 Nov 20. Med Oncol. 2009. PMID: 19021003 Clinical Trial.
-
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer.Mol Ther Nucleic Acids. 2021 Jul 2;26:63-80. doi: 10.1016/j.omtn.2021.06.017. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34513294 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous